...
首页> 外文期刊>Acta Pharmacologica Sinica >Cloning, expression, and characterization of pollen allergens from Humulus scandens (Lour) Merr and Ambrosia artemisiifolia L
【24h】

Cloning, expression, and characterization of pollen allergens from Humulus scandens (Lour) Merr and Ambrosia artemisiifolia L

机译:Hum草和青蒿的花粉变应原的克隆,表达及鉴定

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aim: To clone the pollen allergen genes in Humulus scandens (Lour) Merr (LueCao in Chinese) and short ragweed (Ambrosia artemisiifolia L) for recombinant allergen production and immunotherapy. Methods: The allergen genes were selectively amplified in the weed pollen cDNA pool by using a special PCR profile, with the primers designed by a modeling procedure. Following truncated gene cloning and confirmation of the pollen source, unknown 3′cDNA ends were identified by using the 3′-RACE method. The gene function conferred by the full-length coding region was evaluated by a homologue search in the GenBank database. Recombinant proteins expressed in Escherichia coli pET-44 RosettaBlue cells were subsequently characterized by N-terminal end sequencing, IgE binding, and cross-reactivity. Results: Three full-length cDNAs were obtained in each weed. Multiple alignment analysis revealed that the deduced amino acid sequences were 83% identical to each other and 56%-90% identical to panallergen profilins from other species. Five recombinant proteins were abundantly expressed in non-fusion forms and were confirmed by using the N-terminal end sequence identity. Sera from patients who were allergic to A artemisiifolia reacted not only with rAmb a 8(D03) derived from A artemisiifolia, but also with recombinant protein rHum s 1(LCM9) derived from H scandens, which confirmed the allergenicity and cross-reactivity of the recombinant proteins from the 2 sources. Comparison of the degenerate primers used for truncated gene cloning with the full-length cDNA demonstrated that alternative nucleotide degeneracy occurred. Conclusion: This study demonstrates a useful method for cloning homologous allergen genes across different species, particularly for little-studied species. The recombinant allergens obtained might be useful for the immunotherapeutic treatment of H scandens and/or A artemisiifolia pollen allergies.
机译:目的:克隆Hum草和短豚草(Ambrosia artemisiifolia L)的花粉过敏原基因,用于重组过敏原的生产和免疫治疗。方法:使用特殊的PCR谱,通过建模程序设计引物,在杂草花粉cDNA库中选择性扩增过敏原基因。截短的基因克隆并确认花粉来源后,使用3'-RACE方法鉴定了未知的3'cDNA末端。通过在GenBank数据库中的同源搜索来评估由全长编码区赋予的基因功能。随后通过N末端测序,IgE结合和交叉反应来表征大肠杆菌pET-44 RosettaBlue细胞中表达的重组蛋白。结果:在每个杂草中获得了三个全长cDNA。多重比对分析显示,推导的氨基酸序列与来自其他物种的全变应原profilins彼此相同,分别为83%和56%-90%。五个重组蛋白以非融合形式大量表达,并通过使用N末端序列同一性进行确认。对青蒿素过敏的患者的血清不仅与青蒿素衍生的rAmb a 8(D03)发生反应,而且还与青蒿素衍生的重组蛋白rHum s 1(LCM9)反应,这证实了青蒿素的变应原性和交叉反应性。来自2个来源的重组蛋白。用于全长基因克隆的简并引物与全长cDNA的比较表明,发生了替代核苷酸简并。结论:这项研究证明了一种在不同物种之间,特别是对于研究较少的物种,克隆同源变应原基因的有用方法。获得的重组变应原可用于免疫治疗H scan和/或青蒿花粉过敏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号